| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.24 | 0.0002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.24 | 0.0009 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.001 |